Contraceptives and Dolutegravir-based ART
Latest Information Update: 31 Jul 2023
At a glance
- Drugs Dolutegravir (Primary) ; Levonorgestrel (Primary) ; Medroxyprogesterone (Primary)
- Indications Contraceptive failure
- Focus Pharmacokinetics
- Acronyms CODA
- 25 Jul 2023 Status changed from recruiting to active, no longer recruiting.
- 01 Mar 2022 Status changed from not yet recruiting to recruiting.
- 02 Sep 2021 Planned initiation date changed from 1 Aug 2021 to 1 Oct 2021.